The World Health Organization sounded the alarm Monday about a growing threat of drug-resistant bacteria around the globe that could undermine life-saving treatments, an issue Wayne State University ...

SEOUL, Oct. 14 (UPI) --South Korea's Hyundai ADM Bio said Tuesday that its new cancer drug under development, Penetrium, also may prove effective treating such diseases as rheumatoid arthritis and ...

(Reuters) -U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical, deepening their use of artificial intelligence ...

Drug pricing criticism often fixates on a price at a single point in time but drug pricing is never static. When a new medicine enters the market, it’s common for the “high” initial list price to make ...

Kyorin Pharmaceutical has strengthened its autoimmune portfolio by paying $10 million upfront for the Japanese rights to Hinge Bio’s preclinical lupus drug. The therapy, dubbed HB2198, targets both ...

Armstrong Williams takes on the news of the week and asks the questions you want answered. Don't miss our weekly town hall. by KOMO News Staff TOPICS: SEATTLE, Wash. — Attorney General Nick Brown, ...

Sept 29 (Reuters) - Kala Bio (KALA.O), opens new tab will stop developing its experimental treatment for a type of eye condition after it failed to meet the main goal in a mid-stage study, sending the ...

(CNN) - The Food and Drug Administration will review evidence about the safety and efficacy of the abortion drug Mifepristone. The FDA will also investigate how the drug can be safely dispensed. The ...